http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c8767682410e87636613bc0d5314e94
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Chow |
| name | Elaine Chow |
| given-name | Elaine |
| organization-name | Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, U.K.; Department of Oncology and Metabolism, University of Sheffield, Sheffield, U.K. Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, U.K.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, U.K. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Prince of Wales Hospital,Hong Kong SAR,China; Hong Kong Institute of Diabetes and Obesity,Hong Kong SAR,China; Phase 1 Clinical Trial Center,The Chinese University of Hong Kong,Prince of Wales Hospital,Hong Kong SAR,China Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, West Midlands WV10 0QP 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong; 2Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong; 4Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China; 2Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China Department of Food Science & Technology, University of California, Davis, California, USA Department of Medicine and Therapeutics The Chinese University of Hong Kong Prince of Wales Hospital Hong Kong China; Hong Kong Institute of Diabetes and Obesity The Chinese University of Hong Kong Prince of Wales Hospital Hong Kong China; Phase 1 Clinical Trial Centre The Chinese University of Hong Kong Prince of Wales Hospital Hong Kong China Health Sciences Research Institute (HSRI), Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong (E.L., R.C.M., W.S., A.P.K., E.C., W.G., J.C.C., A.L.) Department of Cardiovascular Science, University of Sheffield, Sheffield, U.K. Department of Medicine and Therapeutics The Chinese University of Hong Kong Prince of Wales Hospital Hong Kong SAR China; Hong Kong Institute of Diabetes and Obesity The Chinese University of Hong Kong Prince of Wales Hospital Hong Kong SAR China Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong. Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong. Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, U.K. Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China Faculty of Medicine, Department of Medicine and Therapeutics The Chinese University of Hong Kong Shatin Hong Kong; Hong Kong Institute of Diabetes and Obesity The Chinese University of Hong Kong Shatin Hong Kong Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region , P. R. China 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China;; 2Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China;; 3Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China;; 4Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China The Chinese University of Hong Kong, Hong Kong, China Department of Medicine and Therapeutics, Prince of Wales Hospital The Chinese University of Hong Kong Shatin Hong Kong; Phase 1 Clinical Trial Centre The Chinese University of Hong Kong Shatin Hong Kong Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China |
Incoming Links
Showing number of triples: 1 to 92 of 92.